By the same authors

From the same journal

From the same journal

Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

Research output: Contribution to journalArticlepeer-review

Standard

Capitalizing hope: the commercial development of umbilical cord blood stem cell banking. / Martin, Paul; Brown, Nik; Turner, Andrew.

In: New Genetics and Society, Vol. 27, No. 2, 06.2008, p. 127-143.

Research output: Contribution to journalArticlepeer-review

Harvard

Martin, P, Brown, N & Turner, A 2008, 'Capitalizing hope: the commercial development of umbilical cord blood stem cell banking', New Genetics and Society, vol. 27, no. 2, pp. 127-143. https://doi.org/10.1080/14636770802077074

APA

Martin, P., Brown, N., & Turner, A. (2008). Capitalizing hope: the commercial development of umbilical cord blood stem cell banking. New Genetics and Society, 27(2), 127-143. https://doi.org/10.1080/14636770802077074

Vancouver

Martin P, Brown N, Turner A. Capitalizing hope: the commercial development of umbilical cord blood stem cell banking. New Genetics and Society. 2008 Jun;27(2):127-143. https://doi.org/10.1080/14636770802077074

Author

Martin, Paul ; Brown, Nik ; Turner, Andrew. / Capitalizing hope: the commercial development of umbilical cord blood stem cell banking. In: New Genetics and Society. 2008 ; Vol. 27, No. 2. pp. 127-143.

Bibtex - Download

@article{502df26ad9874878899840109bb01762,
title = "Capitalizing hope: the commercial development of umbilical cord blood stem cell banking",
abstract = "The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented {"}regime of hope{"}. This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a {"}promissory bioeconomy{"}.",
keywords = "stem cells, cord blood banking, expectations, bioeconomy, TRANSPLANTATION",
author = "Paul Martin and Nik Brown and Andrew Turner",
year = "2008",
month = jun,
doi = "10.1080/14636770802077074",
language = "English",
volume = "27",
pages = "127--143",
journal = "New Genetics and Society",
issn = "1463-6778",
publisher = "Routledge",
number = "2",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

AU - Martin, Paul

AU - Brown, Nik

AU - Turner, Andrew

PY - 2008/6

Y1 - 2008/6

N2 - The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented "regime of hope". This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a "promissory bioeconomy".

AB - The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented "regime of hope". This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a "promissory bioeconomy".

KW - stem cells

KW - cord blood banking

KW - expectations

KW - bioeconomy

KW - TRANSPLANTATION

UR - http://www.scopus.com/inward/record.url?scp=45849095761&partnerID=8YFLogxK

U2 - 10.1080/14636770802077074

DO - 10.1080/14636770802077074

M3 - Article

VL - 27

SP - 127

EP - 143

JO - New Genetics and Society

JF - New Genetics and Society

SN - 1463-6778

IS - 2

ER -